Clinical Trials Sponsored by Institut Rosell

Total 75125 results

University of Michigan Rogel Cancer Center

Terminated

Feasibility Study of Evaluating Breast Cancer Patients With Ductal Lavage

Breast Cancer

United States
University of Michigan Rogel Cancer Center

Terminated

Companion Pharmacogenetic Study to UMCC 9900/9901

Metastatic Breast Cancer

United States
University of Michigan Rogel Cancer Center

Not yet recruiting

Study of Neoadjuvant Enfortumab Vedotin and Pembrolizumab in Cisplatin-eligible Upper Tract Urothelial Cancer (NEPTUNE)

Urothelial Carcinoma

United States
University of Michigan Rogel Cancer Center

Recruiting

Study of Ribociclib Administered Concurrently With Postoperative Radiation Therapy in Patients With High-Risk, Node Positive, HR+/HER2- Breast Cancer

Breast Cancer

United States
University of Michigan Rogel Cancer Center

Recruiting

Multicenter Trial of ESK981 in Patients With Select Solid Tumors

Pancreatic Adenocarcinoma | Pancreatic Neuroendocrine Tumor | Pancreatic Neuroendocrine Carcinoma | Adenosquamous Carcinoma | Gastrointestinal Neuroendocrine Tumor | Gastrointestinal Neuroendocrine Carcinoma | Neuroendocrine Prostate Carcinoma

United States
University of Michigan Rogel Cancer Center

Recruiting

Cardiac Rehabilitation to Improve Breast Cancer Outcomes (CRIBCO)

Cardiovascular Diseases | Breast Cancer

United States
University of Michigan Rogel Cancer Center

Recruiting

Multiparametric MR-Guided High Dose Adaptive Radiotherapy With Concurrent Temozolomide in Patients With Newly Diagnosed Glioblastoma

Glioblastoma

United States
University of Michigan Rogel Cancer Center

Active, not recruiting

Gemcitabine and Cisplatin With or Without CPI-613 as First Line Therapy for Patients With Advanced Unresectable Biliary Tract Cancer (BilT-04)

Biliary Tract Cancer

United States
University of Michigan Rogel Cancer Center

Completed

Altering Lipids for Tolerance of Aromatase Inhibitor Therapy (ALTA)

Breast Cancer

United States
University of Michigan Rogel Cancer Center

Active, not recruiting

Pembrolizumab in Combination With Platinum-Based Chemotherapy in Non-Small Cell Lung Cancer (NSCLC) Patients With Targetable Genetic Alterations, Previously Treated With Appropriate Targeted Agents, With Progressive Disease

Non-small Cell Lung Cancer

United States
University of Michigan Rogel Cancer Center

Terminated

ARRx in Combination With Enzalutamide in Metastatic Castration Resistant Prostate Cancer

Prostate Cancer

United States
University of Michigan Rogel Cancer Center

Completed

Avoiding Low-value Treatments in Older Women With Early-stage Breast Cancer: Piloting a Patient Decision Aid

Breast Cancer

United States
University of Michigan Rogel Cancer Center

Active, not recruiting

A Pilot Study of Metformin Therapy in Patients With Relapsed Chronic Lymphocytic Leukemia (CLL) and Untreated CLL

Relapsed Chronic Lymphocytic Leukemia

United States
University of Michigan Rogel Cancer Center

Withdrawn

Trial of Devimistat in Combination With Modified FOLFIRINOX in Patients With Metastatic Adenocarcinoma of the Pancreas

Metastatic Pancreatic Adenocarcinoma

United States
University of Michigan Rogel Cancer Center

Terminated

Augmentation of the Graft vs. Leukemia Effect Via Checkpoint Blockade With Pembrolizumab

Acute Myeloid Leukemia | Myelodysplastic Syndromes | Acute Lymphoblastic Leukemia

United States
University of Michigan Rogel Cancer Center

Completed

Study of Nivolumab in Combination With Gemcitabine/Cisplatin or Ipilimumab for Patients With Advanced Unresectable Biliary Tract Cancer

Biliary Tract Neoplasms

United States
University of Michigan Rogel Cancer Center

Active, not recruiting

Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma

Mantle Cell Lymphoma

United States
University of Michigan Rogel Cancer Center

Terminated

Testing the Effect of Mindfulness for Prostatectomy Outcomes (TEMPO)

Prostate Cancer

United States
University of Michigan Rogel Cancer Center

Completed

VISmodegib for ORbital and Periocular Basal Cell Carcinoma (VISORB)

Carcinoma, Basal Cell

United States
University of Michigan Rogel Cancer Center

Completed

Peginterferon Alfa-2a to Enhance Anti-leukemic Responses After Allogeneic Transplantation in Acute Myeloid Leukemia

Acute Myeloid Leukemia

United States
University of Michigan Rogel Cancer Center

Terminated

Ipilimumab Induction in Patients With Melanoma Brain Metastases Receiving Stereotactic Radiosurgery

Metastatic Melanoma | Brain Metastases

United States
University of Michigan Rogel Cancer Center

Completed

A Study of High-Dose Chemoradiation Using Biologically-Based Target Volume Definition in Patients With Glioblastoma

Glioma

United States
University of Michigan Rogel Cancer Center

Completed

A Pilot Study of Ruxolitinib in Secondary Hemophagocytic Syndrome

Hemophagocytic Syndrome (HPS)

United States
University of Michigan Rogel Cancer Center

Terminated

Pacritinib in Relapsed/Refractory Lymphoproliferative Disorders

Lymphoproliferative Disorders | Waldenstrom Macroglobulinemia | Mantle Cell Lymphoma | Lymphoma, T-Cell, Cutaneous | Chronic Lymphocytic Leukemia | Lymphoplasmacytic Lymphoma | Lymphoma, T-Cell, Peripheral

United States
University of Michigan Rogel Cancer Center

Completed

Dose Escalation Trial of AZD1775 and Gemcitabine (+Radiation) for Unresectable Adenocarcinoma of the Pancreas

Adenocarcinoma of the Pancreas

United States
University of Michigan Rogel Cancer Center

Completed

A Study of Neoadjuvant FOLFIRINOX and FDR-Gemcitabine With Concurrent IMRT in Patients

Pancreatic Cancer

United States
University of Michigan Rogel Cancer Center

Completed

Pilot Study of Biomarkers and Cardiac MRI as Early Indicators of Cardiac Exposure Following Breast Radiotherapy

Breast Cancer

United States
University of Michigan Rogel Cancer Center

Completed

MRI Study of Changes in Blood-Brain/Tumor-Barrier Permeability in Patients With Brain Metastases During and After Radiotherapy

Brain Metastases

United States
University of Michigan Rogel Cancer Center

Withdrawn

Randomized Trial Comparing Stereotactic Body Radiation Therapy to Microwave Ablation for the Treatment of Localized Hepatocellular Carcinoma

Carcinoma, Hepatocellular

United States
University of Michigan Rogel Cancer Center

Completed

Veliparib With Radiation Therapy in Patients With Inflammatory or Loco-regionally Recurrent Breast Cancer

Breast Cancer

United States
University of Michigan Rogel Cancer Center

Terminated

Phase I/II Calcitriol in Lung Cancer

Non Small Cell Lung Cancer

United States
University of Michigan Rogel Cancer Center

Terminated

Trial Comparing Stereotactic Body Radiation Therapy to Radiofrequency Ablation for Renal Cell Carcinoma

Renal Cell Carcinoma

United States
University of Michigan Rogel Cancer Center

Completed

A Randomized Comparison of Radiation Therapy Techniques in the Management of Node Positive Breast Cancer

Breast Cancer

United States
University of Michigan Rogel Cancer Center

Terminated

Partial Breast Irradiation Using Accelerated Intensity Modulated Radiotherapy

Breast Cancer

United States
University of Michigan Rogel Cancer Center

Withdrawn

Multicenter Study of Pacritinib Combined With Ibrutinib in Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)

Chronic Lymphocytic Leukemia | Lymphoma, Small Lymphocytic

United States
University of Michigan Rogel Cancer Center

Completed

Determine Feasibility of Quantifying Apoptosis and Bcl-2 Expression in CTCs in Women With Metastatic Breast Cancer

Metastatic Breast Cancer

United States
University of Michigan Rogel Cancer Center

Completed

Combination Study of Revlimid®, Velcade® Dexamethasone and Doxil® (RVDD)for Newly Diagnosed Multiple Myeloma (RVDD)

Multiple Myeloma

United States, Canada
University of Michigan Rogel Cancer Center

Completed

A Study of Individualized Stereotactic Body Radiation Therapy (SBRT) for Intrahepatic Cancer

Liver Cancer | Hepatocellular Cancer

United States
University of Michigan Rogel Cancer Center

Completed

Study of Low-Intensity Conditioning for Allogeneic Stem Cell Transplant

Multiple Myeloma | Lymphoma, Low-Grade | Lymphocytic Leukemia, Chronic

United States
University of Michigan Rogel Cancer Center

Terminated

A Pilot Study to Evaluate Neurocognitive Injury and Longitudinal Changes in White Matter During Radiation Therapy in Children With Primary Brain Tumors

Brain Tumor, Primary

United States
University of Michigan Rogel Cancer Center

Terminated

Phase I Study of Vorinostat in Combination With Docetaxel in Patients With Advanced and Relapsed Solid Malignancies.

Prostate Cancer | Bladder Cancer | Urothelial Carcinoma | Non-Small-Cell Lung Carcinoma

United States
University of Michigan Rogel Cancer Center

Completed

A Study Using Cone Beam CT for Head and Neck Cancer

Head and Neck Cancer

United States
University of Michigan Rogel Cancer Center

Completed

Tissue Procurement Protocol for Patients Undergoing Neoadjuvant Systemic Therapy for Breast Cancer

Breast Cancer

United States
University of Michigan Rogel Cancer Center

Completed

Loss of Grip Strength, BMI, and Adjuvant Endocrine Therapy Breast Cancer (LOGRIBMET)

Obesity | Breast Cancer | Arthralgia

United States
University of Michigan Rogel Cancer Center

Completed

The Use of Etanercept Enbrel as Sole Treatment for Grade I Acute Graft Versus Host Disease

Acute Graft Versus Host Disease

United States
University of Michigan Rogel Cancer Center

Terminated

A Pilot Study Assessing Intra-Metastasis Administration of Autologous KLH-pulsed Dendritic Cells With Tumoral Radiation Therapy in Patients With Metastatic Pancreatic Carcinoma

Metastatic Pancreatic Carcinoma

United States
University of Michigan Rogel Cancer Center

Completed

Evaluation of Side Effects and Relative Activity of Two Chemotherapy Regimens in the Treatment Soft Tissue Sarcoma

Sarcoma, Soft Tissue

United States
University of Michigan Rogel Cancer Center

Completed

A Phase II Study of Oral Cyclophosphamide and Sirolimus (OCR) in Advanced Sarcoma (OCR)

Osteosarcoma

United States
University of Michigan Rogel Cancer Center

Completed

Combination Chemotherapy Treatments in Patients With Metastatic Colorectal Cancer

Colorectal Cancer

United States
University of Michigan Rogel Cancer Center

Completed

Tetrathiomolybdate in Hormone Refractory Prostate Cancer

Prostate Cancer

United States

Clinical Trials Sponsored by Institut Rosell

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uruguay

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations